Contribution of single photon emission computed tomography to the differential diagnosis of dementia in a memory clinic

Journal of Alzheimer's Disease

Volumn 30, Issue 4, 2012, Pages 833-845

  Rollin Sillaire, Adeline ^a   Bombois, Stéphanie ^a   Deramecourt, Vincent ^a   Steinert Emptaz, Aline ^a   Salleron, Julia ^b   Morvan, Julie ^a   Maurage, Claude Alain ^a   Steinling, Marc ^a   Pasquier, Florence ^a  

^a UNIV LILLE   (France)

^b UNIV LILLE   (France)

Author keywords

Alzheimer's disease; dementia; frontotemporal lobar degeneration; SPECT

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION SYNDROME; DEGENERATIVE DEMENTIA; DEGENERATIVE DISEASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MEDICAL DEVICE; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY AND SENSIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84863005761     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111067     Document Type: Article

References (44)

1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
2. McKeith IG, DicksonDW,Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ(2005) Diagnosis and management of dementia with Lewy bodies: Third report of theDLBConsortium. Neurology 65, 1863-1872.
3. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F,Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology 43, 250-260.
4. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
5. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47, 1-9.
6. Kumar R, Bergeron C, Pollanen MS, LandAE(1998) Corticobasal ganglionic degeneration. In: Parkinson's disease and Movements Disorders, Jankovic J, Tolosa E, Eds., 3rd Edition, Williams and Wilkins, Baltimore.
7. Boeve BF, Lang AE, Litvan I (2003) Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54(SUPPL. 5), S15-S19.
8. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC (2001) Practice parameter: Diagnosis of dementia (an evidencebased review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 1143-1153.
9. Holmes C, Cairns N, Lantos P, Mann A (1999) Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174, 45-50.
10. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK (1996) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46, 922-930.
11. Litvan I, Agid Y, Goetz C, Jankovic J,Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ (1997) Accuracy of the clinical diagnosis of corticobasal degeneration: Aclinicopathologic study. Neurology 48, 119-125.
12. Dougall NJ, Bruggink S, Ebmeier KP (2004) Systematic reviewof the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 12, 554-570.
13. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B, EFNS (2007) Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 4, e1-e26.
14. Hort J, O'Brien JT, Gainotti G, Pirttila T, Popescu BO, Rektorova I, Sorbi S, Scheltens P(2010) EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol 17, 1236-1248.
15. 3rd Canadian Consensus Conference on Diagnosis and Treatment of Dementia (2007) http://www.cccdtd. ca/pdfs/Final Recommendations CCCDTD 2007.pdf.
16. Bonte FJ, Weiner MF, Bigio EH, White CL III (1997) Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology 202, 793-797.
17. Jobst KA, Barnetson LP, Shepstone BJ (1998) Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDSADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 10, 271-302.
18. JagustW, Thisted R,DevousMDSr,Van Heertum R, Mayberg H, Jobst K, Smith AD, Borys N (2001) SPECT perfusion imaging in the diagnosis of Alzheimer's disease: A clinicalpathologic study. Neurology 56, 950-956.
19. Bonte FJ, Hynan L, Harris TS, White CL (2011) TC-99m HMPAO brain blood flow imaging in the dementias with histopathologic correlation in 73 patients. Int J Mol Imaging 2011, 409101.
20. McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DM, Neary D, Snowden JS, Varma AR (2007) Accuracy of singlephoton emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 78, 350-355.
21. Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A (1995) SPECT in dementia: Clinical and pathological correlation. J Am Geriatr Soc 43, 1243-1247.
22. Le Rhun E, Richard F, Pasquier F (2005) Natural history of primary progressive aphasia. Neurology 65, 887-891.
23. Stokely EM, Sveinsdottir E, Lassen NA, Rommer P (1980) A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections. J Comput Assist Tomogr 4, 230-240.
24. Steinling M, Defebvre L, Duhamel A, Lecouffe P, Lavenu I, Pasquier F, Charpentier P (2001) Is there a typical pattern of brain SPECT imaging in Alzheimer's disease? Dement Geriatr Cogn Disord 12, 371-378.
25. Steinling M, Leys D, Amagassi F, Soetart G, Vernes R. (1989) Can Alzheimer and multi infarct dementia can be differentiated using 99m-Tc-HMPAO tomograms. In: Circulation ćeŕebrale et vieillissement, G Ǵeraud-A B̀es, Eds. John Libbey Eurotext, pp. 291-294.
26. Steinling M, Mazingue A, Kassiotis P, Gaudet Y, Fialdes P, Duhamel A, Dubois P, Vergnes R (1988) HmPaO TC as an indicator of local cerebral blood flow: Quantified study compared to xenon 133 inhalation method. Ann Radiol 31, 229-238.
27. San Pedro EC, Deutsch G, Liu HG, Mountz JM (2000) Frontotemporal decreases in rCBF correlate with degree of dysnomia in primary progressive aphasia. J Nucl Med 41, 228-233.
28. Defebvre L, Lecouffe P, Dest́ee A, Houdart P, Steinling M (1995) Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Acta Neurol Scand 92, 235-241.
29. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC (1995) Patterns of regional cerebral blood flowin corticobasal degeneration studied usingHMPAOSPECT; comparison with Parkinson's disease and normal controls. Mov Disord 10, 179-187.
30. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ (1998)A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry 64, 306-313.
31. DeramecourtV, Lebert F, Debachy B,Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, Búee L, Maurage CA, Pasquier F (2010) Prediction of pathology in primary progressive language and speech disorder. Neurology 74, 42-49.
32. Ball MJ, Braak H, Coleman P, Dickson D, Duyckaerts C, Gambetti P, Hansen L, Hyman B, Jellinger K, Markesbery W, Perl D, Powers J, Price J, Trojanowski JQ, Wisniewski H (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease: The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18, S1-S2.
33. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE,Tolnay M, Okamoto K, Yokoo H, Murayama S, Woulfe J, Munoz DG, Dickson DW, Ince PG, Trojanowski JQ, Mann DM(2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 114, 5-22.
34. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T (2004) Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 226, 75-80.
35. Ince PG. (2005) Acquired forms of vascular dementia. In: Cerebrovascular diseases, Kalimo H, Eds. ISN Neuropath Press, Basel, pp. 316-323.
36. Balasa M, Gelpi E, Antonell A, Rey MJ, Śanchez-Valle R, Molinuevo JL, Llad́oA(2011) Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease. Neurology 76, 1720-1725.
37. AshfordJW(2008) Screening for memory disorder, dementia, and Alzheimer's disease. Aging Health 4, 399-432.
38. Hanyu H, Shimuzu S, Tanaka Y, Takasaki M, Koizumi K, Abe K (2004) Cerebral blood flow patterns in Binswanger's disease: A SPECT study using three-dimensional stereotactic surface projections. J Neurol Sci 15, 79-84.
39. Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65, 278-288.
40. Høgh P, Teller AS, Hasselbalch S, Waldemar G (2007) Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: A comparative study. Dement Geriatr Cogn Disord 24, 429-433.
41. Minoshima S, Foster NL, Kuhl DE (1994) Posterior cingulate cortex in Alzheimer's disease. Lancet 344, 895.
42. Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer's disease. Lancet Neurol 2, 605-613.
43. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746.
44. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7, 263-269.